Browse Category

NASDAQ:STEM News 15 October 2025

Stem, Inc. (NASDAQ: STEM) Stock Skyrockets on European Expansion and Analyst Upgrades

Stem, Inc. (NASDAQ: STEM) Stock Skyrockets on European Expansion and Analyst Upgrades

European Expansion Spurs Stock Rally Stem’s most recent catalyst was a BusinessWire announcement on Oct. 14 detailing a new 400 m² Berlin hub to support large-scale solar, storage and hybrid (solar-plus-storage) projects in Europe Stocktitan. Management calls this the company’s “European competence center,” doubling workspace for engineering and support teams. Arun Narayanan (CEO) said: “This expansion underscores Stem’s commitment to embed engineering and customer expertise directly in Europe… By expanding in Berlin, we’re strengthening local capabilities to deliver faster commissioning and the post-sales support… for successful solar and storage projects” Stocktitan. President of Software Products Matt Tappin added that Berlin’s central
15 October 2025

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop